BCYC
Bicycle Therapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$4.30
+1.42%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- -$0.40
- Revenue estimate
- $12.2M
Latest reported
- Last report date
- Jul 30, 2026
- EPS actual
- -$0.72
- EPS estimate
- -$0.56
- Revenue actual
- $629.0K
- Revenue estimate
- $4.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +4.6%
- Revenue beats (12Q)
- 5
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026